Kura Oncology has launched Caspian Therapeutics, a separately financed company to develop small-molecule menin inhibitors for diabetes and cardiometabolic diseases. The move extends Kura’s menin expertise beyond oncology and broadens its strategic focus.
published
Kura Oncology has launched Caspian Therapeutics, a separately financed company to develop small-molecule menin inhibitors for diabetes and cardiometabolic diseases. The move extends Kura’s menin expertise beyond oncology and broadens its strategic focus.
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.